Influenza and antiviral treatment: SAQ

This infant presents the archetypal paediatric influenza scenario: an unwell infant in influenza season with an affected household contact, atypical respiratory distress rather than the classic abrupt febrile illness of an older child, and then the feared biphasic deterioration that signals secondary bacterial pneumonia. Recognising both phases — the early empiric antiviral window and the later septic deterioration — is what the question tests. [2]

Question 1 (10 marks)

Outline your initial assessment, investigations and the rationale for early oseltamivir in this infant. [2]

Begin with a structured airway, breathing and circulation assessment. This infant is in respiratory distress with intercostal recession and an oxygen saturation of 91 percent in air, so he needs immediate oxygen, continuous monitoring and a low threshold for escalation. Measure a full set of vital signs including temperature, respiratory rate, heart rate, blood pressure and capillary refill, and weigh him for drug dosing. Assess feeding tolerance, hydration and urine output, and examine for the complications that change disposition — dehydration, altered conscious state, and the tachycardia and poor perfusion of myocarditis. [2]

The history is itself diagnostic. The mid-winter presentation, the household contact with confirmed influenza, and the infant's fever with poor feeding and respiratory distress make influenza the leading working diagnosis. In an infant, influenza may present without the classic cough-and-myalgia story of an older child; fever, poor feeding, irritability, lethargy or apnoea, and a sepsis-like picture can be the whole illness, and influenza belongs in the differential of the unwell infant alongside bronchiolitis, sepsis and urinary infection. [2]

Send a nasopharyngeal aspirate or flocked swab for influenza PCR, ideally as part of a respiratory-virus panel. A full blood count, electrolytes, C-reactive protein and blood cultures are reasonable in a sick infant to stage severity and to detect bacterial co-infection, and a chest X-ray is indicated given the respiratory distress and hypoxia. The key principle is that a sick child should never wait for the PCR result before starting antivirals — a positive test later only confirms what the severity demanded up front. [2]

Start oseltamivir empirically. The landmark treatment trial established that oseltamivir shortened illness and reduced acute otitis media in children, and pharmacokinetic work established safe, effective age-specific dosing for infants and neonates under two years. Severity, not the clock, drives treatment in the hospitalised child, and this infant — under two, hypoxic and unwell — meets every criterion for early empiric antiviral therapy. Dose by weight and age for a five-day course, and place the child under droplet precautions throughout the admission. [1]

Question 2 (10 marks)

Describe your management of the day-three deterioration, including the diagnosis, the change in therapy, and the prevention message for the family. [3]

The biphasic course is the classic sign of secondary bacterial pneumonia. A child who improves for a day or two after influenza onset and then spikes a new fever with worsening breathlessness, mottling and grunting has developed secondary bacterial pneumonia until proven otherwise. The seminal surveillance of influenza-associated deaths in children showed that bacterial co-infection — most often Staphylococcus aureus including methicillin-resistant strains, Streptococcus pneumoniae and Haemophilus influenzae — drove much of the fatal deterioration, and that this occurred in previously healthy as well as high-risk children. [3]

Reassess the airway, breathing and circulation immediately. This infant is now in shock with mottling and grunting, so he needs fluid resuscitation with 10 mL per kilogram boluses of isotonic crystalloid titrated to perfusion, high-flow oxygen, and escalation of respiratory support. Repeat the blood cultures, inflammatory markers and chest X-ray, and prepare for transfer to a higher-acuity setting; the intensive-care series during the 2009 pandemic showed that respiratory failure and shock from viral and secondary bacterial pneumonia were the dominant reasons for PICU admission. [4]

Add empirical intravenous antibiotics immediately, covering the organisms that cause post-influenza secondary bacterial pneumonia. A regimen covering Staphylococcus aureus including methicillin-resistant strains, Streptococcus pneumoniae and Haemophilus influenzae is required, for example a third-generation cephalosporin with the addition of an anti-staphylococcal agent such as flucloxacillin or vancomycin where MRSA is prevalent or the child is critically ill. Continue the oseltamivir to complete the five-day course, because the viral infection and the bacterial complication coexist. [3]

Complete the public-health and prevention essentials. Notify the case where required, maintain droplet precautions, identify the household and close contacts, and offer post-exposure prophylaxis to any high-risk contacts. At discharge, reinforce the prevention message for the family: this infant is now eligible for the annual influenza vaccine (two doses in the first season he receives it), the household should be vaccinated to protect him and any future infant, and maternal vaccination in any future pregnancy would have transferred antibody through the first months of life. The clinical encounter does not end when the child improves — it ends when the contacts are protected and the family is vaccinated. [3]